Venus Remedies Balance Sheet
- Market cap
- ₹2,165 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹1,166.11 – ₹2,186.46
As of FY25, Venus Remedies had total assets of ₹1,407 crore and borrowings of ₹260 crore, against shareholders' equity of ₹1,094 crore — a debt-to-equity ratio of 0.35.
Venus Remedies balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 974 |
| Borrowings | 260 |
| Other liabilities | 173 |
| Total liabilities | 1,407 |
| Fixed assets | 758 |
| Capital work in progress | 45 |
| Investments | 325 |
| Other assets | 325 |
| Total assets | 1,407 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹568.28
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Venus Remedies balance sheet — frequently asked questions
What is the total debt of Venus Remedies?
Venus Remedies reported borrowings of ₹260 crore as of FY25.
What is Venus Remedies' debt-to-equity ratio?
Based on the FY25 balance sheet, Venus Remedies' debt-to-equity ratio is 0.35 — borrowings of ₹260 crore against equity capital and reserves of ₹1,094 crore.
What are Venus Remedies' total assets?
Venus Remedies' total assets were ₹1,407 crore as of FY25, including fixed assets of ₹758 crore and investments of ₹325 crore.
What is the book value per share of Venus Remedies?
The book value per share of Venus Remedies is ₹568.28, based on the latest reported balance sheet.
Same Data For Peers
Trade Venus Remedies With ATS
Track VENUSREM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.